Chemical Structure : HAMI3379
CAS No.: 1245653-57-9
Catalog No.: PC-35285Not For Human Use, Lab Use Only.
HAMI3379 (HAMI-3379) is a potent and selective antagonist of cysteinyl leukotriene 2 (CysLT(2)) receptor, inhibits LTD4- and LTC4-induced intracellular calcium mobilization withIC50 of 3.8 nM and 4.4 nM respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $198 | In stock | |
10 mg | $298 | In stock | |
25 mg | $498 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
HAMI3379 (HAMI-3379) is a potent and selective antagonist of cysteinyl leukotriene 2 (CysLT(2)) receptor, inhibits LTD4- and LTC4-induced intracellular calcium mobilization withIC50 of 3.8 nM and 4.4 nM respectively.
HAMI3379 exhibits very low potency on a recombinant CysLT(1) receptors (IC50>10 uM), does not exhibit any agonistic activity on both CysLT receptors.
HAMI3379 concentration-dependently inhibits and reverses the LTC(4)-induced perfusion pressure increase and contractility decrease in isolated Langendorff-perfused guinea pig hearts, protects against acute brain injury after focal cerebral ischemia in rats.
M.Wt | 595.733 | |
Formula | C34H45NO8 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
3-({[(1S,3S)-3-carboxycyclohexyl]amino}carbonyl)-4-(3-{4-[4-(cyclo-hexyloxy)butoxy]phenyl}propoxy) benzoic acid |
1. Merten N, et al. Cell Chem Biol. 2018 Jun 21;25(6):775-786.e5.
2. Wunder F, et al. Br J Pharmacol. 2010 May;160(2):399-409.
3. Shi QJ, et al. Brain Res. 2012 Nov 12;1484:57-67.
4. Zhang XY, et al. J Pharmacol Exp Ther. 2013 Aug;346(2):328-41.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright